V. Riccardi

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.

Michael Fisher, A. Stemmer-Rachamimov, B. Korf, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: A cohort study of 703 patients

K. Khosrotehrani, P. Wolkenstein, S. Bastuji‐Garin, 2005, American journal of medical genetics. Part A.

The biology of cutaneous neuro fi bromas Consensus recommendations for setting research priorities

R. Lavker, J. Brosseau, E. Legius, 2022 .

The French—American—British (FAB) classification of leukemia. The pediatric oncology group experience with lymphocytic leukemia

Jimmie T. Boyett, D. Head, J. Pullen, 1986, Cancer.

Spinal schwannomatosis

S. Pulst, V. Mautner, V. Riccardi, 1997, Neurology.

Analysis of neurofibromatosis 1 (NF1) lesions by body segment

V. Riccardi, J. Friedman, H. Joe, 2004, American journal of medical genetics. Part A.

A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching.

V. Riccardi, V. Riccardi, 1993, Archives of dermatology.

Ocular Abnormalities in Neurofibromatosis 2

S. Pulst, J. Sainz, V. Riccardi, 1995 .

Associations of clinical features in neurofibromatosis 1 (NF1)

V. Riccardi, J. Szudek, P. Birch, 2000, Genetic epidemiology.

Current clinical and pathologic issues

Douglas C. Miller, A. Stemmer-Rachamimov, B. Korf, 2022 .